Il rapporto
Analisi approfondite sul finanziamento aziendale, strategie di crescita e approfondimenti di mercato dalle aziende più innovative del mondo
4 report e oltre
Zymergen Raises $575M in Series D
Zymergen, a Biotech company based in 5980 Horton Street, Emeryville, CA 94608, has raised $575M in Series D at a $3.2B valuation led by SoftBank Vision Fund, DCVC, True Ventures, Data Collective, Two Sigma Ventures.
Zymergen raises $130M Series C at $560M valuation
Zymergen raises $130M in Series C at $560M valuation. Bio-based materials and molecule development...
Zymergen raises $575M Series D at $3.2B valuation
Zymergen raises $575M in Series D at $3.2B valuation. Bio-based materials manufacturing...
Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation
Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.
Visualizzazione di 4 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.